Risk-dependent conditional survival analysis and annual hazard rate of primary ocular adnexal lymphoma

风险依赖性条件生存分析和原发性眼附属器淋巴瘤的年度风险率

阅读:3

Abstract

BACKGROUND: The real-time prognosis of patients with primary ocular adnexal lymphoma (POAL) who have survived for several years remains uncertain. Our objective was to assess survival dynamics over time in POAL using conditional survival (CS) analysis and annual hazard functions. METHODS: We utilized data from the SEER database (2004–2019) to conduct CS analysis on POAL patients. A total of 1901 patients were included. CS was estimated using the Kaplan–Meier method, and the annual hazard rate (AHR) was calculated to examine changes in mortality risk over time. A predictive nomogram incorporating CS analysis was developed using a random survival forest (RSF) approach, with model performance evaluated through calibration, concordance index (C-index), receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). RESULTS: CS analysis revealed a significant improvement in survival over time, with 10-year CS rates increasing from 69% at diagnosis to over 96% for patients surviving 1–9 years. The AHR peaked at 4.1% in the first year, declining progressively to 1.7% by year 10. The RSF algorithm identified five key prognostic factors—age, tumor site, histology, tumor stage, and radiotherapy—as important predictors. A CS-based nomogram was developed, and its reliability was further confirmed through calibration curves, C-index values, and ROC analysis, with AUC values exceeding 0.80 for 3-, 5-, and 10-year survival predictions. CONCLUSIONS: This study outlined the changes in CS prognosis and AHR for patients with POAL. Furthermore, we developed a CS-based nomogram using SEER data, which effectively integrated dynamic survival improvements and time-dependent risk factors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-026-04800-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。